Neurovascular Surgical Devices Market, Global, 2025–2029

Revenue Forecast

The revenue estimate for the base year is $3.27 billion, with a CAGR of 7.5% for the study period of 2024–2029.

The Impact of the Top 3 Strategic Imperatives on the Neurovascular Surgical Devices Industry

Disruptive Technologies

WHY

Clinicians leverage new-age AI, robotics, and imaging technologies to improve prevention, diagnosis, and treatment.

Common rehabilitation usually assists only about 50% of stroke patients in recovering their walking ability, necessitating more advanced rehabilitation solutions.

FROST PERSPECTIVE

The lack of continuous post-procedure monitoring increases the risk of undetected complications, such as recollision or device migration.

Solutions such as smart stents and coils with embedded sensors provide real-time data on blood flow, pressure, and healing progress.

In addition, wireless communication capabilities allow remote monitoring by healthcare providers, reducing the need for frequent imaging follow-ups.

Innovative Business Models

WHY

Innovative business models reflect the evolving needs of the neurovascular surgery market, driven by technological advancements, cost pressures, and the demand for personalized care.

By adopting these strategies, companies can enhance their competitiveness, improve patient outcomes, and expand their global reach.

FROST PERSPECTIVE

Partnerships among start-ups, academic institutions, and clinicians drive the development of next-generation devices.

Industry participants increasingly focus on solutions that address timely care coordination between the patient and caregiver, preventive health, and first aid ambulatory care for optimal stroke care.

Transformative Megatrends

WHY

Improvements in stroke prevention, acute treatment, and neuro-rehabilitation contribute significantly to a reduction in the burden of stroke in high-income countries.

Neurovascular solutions companies recognize the importance of optimized solutions at the various stages for stroke management, apart from just utilizing a treatment-centric approach.

FROST PERSPECTIVE

AI and machine learning algorithms enhance neurovascular imaging, aiding in the detection of aneurysms, stroke, and other abnormalities and improving procedural accuracy.

RapidaV for stroke imaging and decision support is used across over 100 countries at more than 2,000 hospitals.

Vizi.ai for real-time imaging analysis and triage is implemented in over 1,400 hospitals, primarily in the United States and the EMEA region. It covers nearly two-thirds of the US population through hospital networks.

Scope of Analysis

• This study provides a detailed overview of the neurovascular surgical devices market, covering various aspects driving its growth.
• It examines the various devices used in neurovascular surgical procedures, including neurovascular stents, neurovascular embolization devices, neurovascular thrombectomy devices, and neurovascular catheters.
• The market overview section evaluates growth prospects in the following categories:
  • Global revenue forecast
  • Revenue forecasts by region and product type
  • Market sizing using historical and forecast data by segment and region
• It also outlines the competitive landscape, challenges and drivers, trends, and growth opportunities.
• The geographic scope covers North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

Growth Drivers

The increased use of minimally invasive techniques in neurological and cerebrovascular surgeries is leading to enhanced diagnostics and the treatment of brain-related blood vessel disorders.

Simulation technology and AI-based image triaging solutions will help build neurointerventional expertise and drive the adoption of advanced procedures in the standard of care. Neurovascular disease management companies are working to improve haptic feedback technology for simulation technologies.

The shift from open surgery to endovascular procedures is a key trend, as devices such as flow diverters, thrombectomy devices, and coils are increasingly used for minimally invasive treatments.

Positive clinical trial data for new treatment applications, such as unruptured brain aneurysms and brain arteriovenous malformations, will expand the application of surgical treatment devices.

Flexibility and customization of treatment guidelines that extend beyond existing selection criteria to include consideration of advanced infrastructure for endovascular procedures and individual patient characteristics will drive surgical implementation.

Growth Restraints

The high cost of advanced neurovascular devices such as stent retrievers, embolization coils, and thrombectomy devices can limit their accessibility, particularly in cost-sensitive regions.

Hospitals with limited budgets or those in emerging markets may struggle to afford advanced technologies, delaying the adoption of the latest devices.

Lengthy approval processes make it difficult for companies to introduce innovative devices quickly, potentially allowing competitors to capture market share in the interim.

The scarcity of trained specialists can hinder the widespread adoption of these devices, particularly in underserved regions, as high-quality training programs and education in neurovascular surgery are costly, and many hospitals or medical centers may not have the budget to support ongoing training for their staff.

Competitive Environment

Number of Competitors: 120 with revenue greater than $1.0 million
Competitive Factors: Cost, performance, schedule, support, technology, reliability, contractor relationships, customer relationships
Key End-user Industry Verticals: Hospitals, Specialty Clinics, and Ambulatory Surgical Centers
Leading Competitors: Stryker, Medtronic, Terumo Neuro, Penumbra
Revenue Share of Top 4 Competitors (2024) 93.0%
Other Notable Competitors: MicroPort Scientific Corp, J&J, Acandis, Boston Scientific, Asahi Intec, Balt Group
Distribution Structure: OEMs, retail sales, direct sales
Notable Acquisitions and Mergers: Boston Scientific closed acquisition of Silk Road Medical (Sep 17, 2024)

Key Competitors

• Stryker
• Acandis
• Abbott
• Medtronic
• MicroPort Scientific
• Boston Scientific
• Penumbra
• Balt
• Silk Road Medical
• Hellman & Friedman
• Medtronic
• Johnson & Johnson
• Wallaby Medical
• Terumo Neuro
• Stryker
• Cerenovus
• Phenox
• MicroVention
• Imperative Care
• Rapid Medical
• Penumbra
• Balt
• Acandis
• Medtronic
• Stryker
• Terumo Neuro
• Johnson & Johnson
• Integra LifeSciences
• MicroVention
• Cerenovus
• Balt
• B Braun Melsungen
• Phenox
• Acandis
• Balt
• Shape Memory Medical
• Medtronic
• Nordson Corporation
• Stryker
• Terumo Neuro
• Imperative Care
• Integer Holdings
• Penumbra
• Johnson & Johnson
• Integra LifeSciences